Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Viemed Healthcare (VMD) Profit After Tax (2018 - 2026)

Viemed Healthcare filings provide 8 years of Profit After Tax readings, the most recent being $5.6 million for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 31.75% to $5.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.1 million, a 34.15% increase, with the full-year FY2025 number at $14.9 million, up 32.57% from a year prior.
  • Profit After Tax hit $5.6 million in Q4 2025 for Viemed Healthcare, up from $3.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $5.6 million in Q4 2025 to a low of $967000.0 in Q2 2022.
  • Median Profit After Tax over the past 5 years was $2.4 million (2022), compared with a mean of $2.6 million.
  • Biggest five-year swings in Profit After Tax: plummeted 91.93% in 2021 and later skyrocketed 176.68% in 2023.
  • Viemed Healthcare's Profit After Tax stood at $4.1 million in 2021, then plummeted by 40.35% to $2.4 million in 2022, then surged by 42.62% to $3.5 million in 2023, then increased by 23.09% to $4.3 million in 2024, then soared by 31.75% to $5.6 million in 2025.
  • The last three reported values for Profit After Tax were $5.6 million (Q4 2025), $3.5 million (Q3 2025), and $3.2 million (Q2 2025) per Business Quant data.